FDA Emails Offer Rare Look Into Internal Battle Over a Drug's Approval

The Food and Drug Administration provided a rare glimpse of an internal battle that erupted last year over efforts to modernize the agency’s efforts to approve and regulate new drugs.

from WSJ.com: US Business http://ift.tt/2wqv0Oh
via IFTTT